Low Molecular Weight Heparin vs Direct Oral Anticoagulant After Bariatric Surgery
NCT ID: NCT06913595
Last Updated: 2025-08-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
PHASE1
100 participants
INTERVENTIONAL
2024-03-25
2025-11-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Rivaroxaban Versus Enoxaparin for Prophylaxis of Venous Thromboembolism in Bariatric Surgery
NCT06689241
Laparoscopic Bariatric Surgery: Two Regimens of Venous Thromboprophylaxis: Prospective Randomized Study
NCT02128178
Effectiveness and Tolerability of Phentermine in Patients Under Bariatric Surgery
NCT03849729
Ketamine Infusion vs Dexmedetomidine Infusion in Obese Patients Undergoing Bariatric Surgery
NCT04576975
Thromboprophylaxis and Bariatric Surgery
NCT00444652
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Low Molecular Weight Heparin
Low molecular weight heparin as aprophylaxis after bariatric surgery
Low Molecular Weight Heparine
Low molecular weight heparin after bariatric surgery
Direct Oral Anticoagulant.
Direct Oral Anticoagulant as aprophylaxis after bariatric surgery
Direct Oral Anticoagulant.
Direct Oral Anticoagulant AFTER BARIATRIC SURGERY
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Direct Oral Anticoagulant.
Direct Oral Anticoagulant AFTER BARIATRIC SURGERY
Low Molecular Weight Heparine
Low molecular weight heparin after bariatric surgery
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cairo University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mohammed Elshwadfy Nageeb
lecturer of general surgery
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
mohammed elshwadfy
Role: PRINCIPAL_INVESTIGATOR
Cairo University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cairo University
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
N-55-2024
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.